ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
Red Cat Holdings, Inc. Announces Closing of Public Offering
-
Twin Vee PowerCat (VEEE) IPO Opens 12% Higher
-
Twin Vee PowerCats, Co. (VEEE) Prices 3M Share IPO at $6/sh
-
Twin Vee PowerCats Co. Announces Pricing of Initial Public Offering
-
Opportunity Financial (“OppFi”) and FG New America Acquisition Corp. Complete Business Combination
-
Marpai, Inc (MRAI) Files For up to $30M IPO
-
Red Cat Holdings Inc. (RCAT) Prices 13.3M Share Offering at $4.50/sh
-
Red Cat Holdings, Inc. Announces Pricing of Public Offering
-
Red Cat Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
Pyxis Tankers Announces Closing of $6.17 Million Follow-on Public Offering of Convertible Preferred Shares
-
Pyxis Tankers Inc. (PXS) Announces Pricing of Public Offering of Series A Cumulative Convertible Preferred Stock
-
Pyxis Tankers Announces Pricing of Public Offering of Series A Cumulative Convertible Preferred Stock
-
TransCode Therapeutics, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Over-allotment Option
-
EVmo Announces Closing of $15 Million Debt Financing to Drive Fleet and Market Expansion
-
TransCode Therapeutics, Inc (RNAZ) Prices 6.25M Share IPO at $4/sh
-
TransCode Therapeutics, Inc. Announces Pricing of Initial Public Offering
-
OMNIQ Corp Announces Closing of Private Placement of Unregistered Common Stock and Acquisition of 51% of Dangot Computers
-
VBL Therapeutics (VBLT) Appoints Alison Finger and Michael Rice to its Board of Directors
-
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
-
Kiromic BioPharma, Inc. Announces Closing of Public Offering
-
Context Therapeutics Inc. (CNTX) Files 1.5M Share IPO at $12-$14/sh
-
Twin Vee PowerCats Co. (VEEE) Announce 2M Share Offering at $5-$6/sh
-
cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceed
-
iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering
-
Kiromic BioPharma (KRBP) Prices 8M Share IPO at $5/sh
-
Kiromic BioPharma, Inc. Announces Pricing of Public Offering
-
CardioFocus Appoints Stephan Ogilvie as Chief Financial Officer
-
cbdMD, Inc. Announces Pricing of $14.3 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering
-
Second Sight Medical Products Announces Closing of Public Offering
-
Second Sight Medical (EYES) Prices 10M Share Offering at $5/sh
-
Second Sight Medical Products Announces Pricing of Public Offering
-
Second Sight Medical (EYES) Announces Proposed Offering, Size not Disclosed
-
Second Sight Medical Products Announces Proposed Public Offering of Common Stock
-
FAT Brands Inc. Announces Closing of Public Offering of Series B Cumulative Preferred Stock and Full Exercise of Underwriter’s Overallotment Option
-
FAT Brands Inc. Announces Closing of Public Offering of Series B Cumulative Preferred Stock and Full Exercise of Underwriter’s Overallotment Option
-
iSpecimen Announces Closing of Initial Public Offering
-
Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock
-
FAT Brands Inc. Announces Pricing of Public Offering of Series B Cumulative Preferred Stock
-
FAT Brands Inc. Announces Pricing of Public Offering of Series B Cumulative Preferred Stock
-
iSpecimen (ISPC) IPO Opens 22% Lower
-
iSpecimen (ISPC) IPO Prices at $8
-
iSpecimen Announces Pricing of Initial Public Offering
-
Inhibikase Therapeutics (IKT) Prices 15M Shares at $3
-
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
-
Harbor Custom Development, Inc. Announces Closing of $30.0 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Closing of $30.0 Million Public Offering of Convertible Preferred Shares & Warrants
-
Cardiff Oncology Announces the Appointment of Two New Independent Members to its Board of Directors
-
BK Technologies Corporation Announces Closing of Public Offering, Including Full Exercise of Underwriters' Over-allotment Option
-
Harbor Custom Development (HCDI) Announces Pricing of $30 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Pricing of $30 Million Public Offering of Convertible Preferred Shares & Warrants

